They Prepare to accomplish this next period III research by the end of this 12 months. After the section III is full, MAPS will make an application for FDA approval for MDMA therapy. They foresee FDA approval to come in late 2023. After it is approved, the DEA should have https://droguerieviral.com/product/buy-amphetamine/